Stock & Company Details
Candel Therapeutics Inc $CADL
Price:
N/A
N/A
77M
$739M
52 Week High:
N/A
10 Day Average Volume:
N/A
-9.88
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CADL technical indicators
Latest Candel Therapeutics Inc (CADL) indicator readings as of 2026-10-09.
CADL's 14-day RSI is 38.7, in neutral territory. At $9.94 it is trading 23.1% above its 200-day moving average of $8.07, and below its 50-day average of $11.46. Price sits near the lower Bollinger Band ($9.47 to $11.96). ADX reads 28.4, indicating a trending market.
Overview
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Finance Bot
Ask your questions
Start by typing a question below.
